Shenqi compound ameliorates type-2 diabetes mellitus by modulating the gut microbiota and metabolites
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Shenqi compound ameliorates type-2 diabetes mellitus by modulating the gut microbiota and metabolites
Authors
Keywords
Type 2 diabetes mellitus, Shenqi compound, Glycemic variability, Intestinal mucosal barrier, Gut microbiota, Metabolites
Journal
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
Volume 1194, Issue -, Pages 123189
Publisher
Elsevier BV
Online
2022-02-24
DOI
10.1016/j.jchromb.2022.123189
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global and regional estimates and projections of diabetes-related health expenditure: results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2020) Rhys Williams et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Examination of nicotine and saccharin reward in the Goto-Kakizaki diabetic rat model
- (2020) Janell R. Richardson et al. NEUROSCIENCE LETTERS
- Role of gut microbiota in type 2 diabetes pathophysiology
- (2020) Manoj Gurung et al. EBioMedicine
- Lactobacillus rhamnosus GG treatment improves intestinal permeability and modulates microbiota dysbiosis in an experimental model of sepsis
- (2019) Lufang Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Exploration of the Effect and Mechanism of ShenQi Compound in a Spontaneous Diabetic Rat Model
- (2019) Ya Liu et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Metabolomics of Type 1 and Type 2 Diabetes
- (2019) Borros Arneth et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Saxagliptin attenuates glomerular podocyte injury by increasing the expression of renal nephrin and podocin in type 2 diabetic rats
- (2019) Yuanyuan Hu et al. ACTA DIABETOLOGICA
- WITHDRAWN: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2019) Pouya Saeedi et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats
- (2019) Minchun Zhang et al. BMJ Open Diabetes Research & Care
- Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition
- (2019) Rinninella et al. Nutrients
- Lycium barbarum L. leaves ameliorate type 2 diabetes in rats by modulating metabolic profiles and gut microbiota composition
- (2019) Xue-qin Zhao et al. BIOMEDICINE & PHARMACOTHERAPY
- The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: new insights into old diseases
- (2019) Alessia Pascale et al. CURRENT OPINION IN PHARMACOLOGY
- Oral hydroxysafflor yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism
- (2018) Juan Liu et al. PHARMACOLOGICAL RESEARCH
- Modulation of the diet and gastrointestinal microbiota normalizes systemic inflammation and β-cell chemokine expression associated with autoimmune diabetes susceptibility
- (2018) Angela M. Henschel et al. PLoS One
- Transglycosylated Starch Modulates the Gut Microbiome and Expression of Genes Related to Lipid Synthesis in Liver and Adipose Tissue of Pigs
- (2018) Monica A. Newman et al. Frontiers in Microbiology
- Glycaemic variability in diabetes: clinical and therapeutic implications
- (2018) Antonio Ceriello et al. Lancet Diabetes & Endocrinology
- UPLC-Q/TOF-MS-Based Serum Metabolomics Reveals Hypoglycemic Effects of Rehmannia glutinosa, Coptis chinensis and Their Combination on High-Fat-Diet-Induced Diabetes in KK-Ay Mice
- (2018) Zhenxian Qin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Comparison of efficacy of SHENQI compound and rosiglitazone in the treatment of diabetic vasculopathy analyzing multi-factor mediated disease-causing modules
- (2018) Hong Gao et al. PLoS One
- Gut microbiome production of short-chain fatty acids and obesity in children
- (2017) Selvasankar Murugesan et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Deciphering Diversity Indices for a Better Understanding of Microbial Communities
- (2017) Bo-Ra Kim et al. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals
- (2017) Mansour Sedighi et al. MICROBIAL PATHOGENESIS
- Gut Microbiota and Host Metabolism: What Relationship
- (2017) Gilles Mithieux NEUROENDOCRINOLOGY
- Short Chain Fatty Acids in the Colon and Peripheral Tissues: A Focus on Butyrate, Colon Cancer, Obesity and Insulin Resistance
- (2017) Sean McNabney et al. Nutrients
- Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota
- (2017) Ming Lyu et al. Frontiers in Microbiology
- Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis
- (2016) Marta Guasch-Ferré et al. DIABETES CARE
- Human gut microbes impact host serum metabolome and insulin sensitivity
- (2016) Helle Krogh Pedersen et al. NATURE
- The Relationship between Branched-Chain Amino Acid Related Metabolomic Signature and Insulin Resistance: A Systematic Review
- (2016) Xue Zhao et al. Journal of Diabetes Research
- The role of microbiota in compensatory growth of protein-restricted rats
- (2016) Yizhi Zhu et al. Microbial Biotechnology
- Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
- (2015) Kristoffer Forslund et al. NATURE
- Short-chain fatty acids in control of body weight and insulin sensitivity
- (2015) Emanuel E. Canfora et al. Nature Reviews Endocrinology
- Role of the Gut Microbiome in Obesity and Diabetes Mellitus
- (2015) Gillian M. Barlow et al. NUTRITION IN CLINICAL PRACTICE
- Role of the normal gut microbiota
- (2015) Sai Manasa Jandhyala WORLD JOURNAL OF GASTROENTEROLOGY
- Obesity and the microbiome
- (2015) Ruchi Mathur et al. Expert Review of Gastroenterology & Hepatology
- jvenn: an interactive Venn diagram viewer
- (2014) Philippe Bardou et al. BMC BIOINFORMATICS
- Protective effect of 7-O-succinyl macrolactin A against intestinal inflammation is mediated through PI3-kinase/Akt/mTOR and NF-κB signaling pathways
- (2014) Sumin Park et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Glucose variability: An emerging target for the treatment of diabetes mellitus
- (2013) Simona Frontoni et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity
- (2013) Marlene Remely et al. GENE
- The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome ‘at-risk’ population
- (2012) F Fava et al. INTERNATIONAL JOURNAL OF OBESITY
- Gut Microbial Activity, Implications for Health and Disease: The Potential Role of Metabolite Analysis
- (2012) Edna. P. Nyangale et al. JOURNAL OF PROTEOME RESEARCH
- A metagenome-wide association study of gut microbiota in type 2 diabetes
- (2012) Junjie Qin et al. NATURE
- Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes
- (2010) Susan C. Connor et al. Molecular BioSystems
- Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
- (2010) Nadja Larsen et al. PLoS One
- Human gut microbiome: the second genome of human body
- (2010) Baoli Zhu et al. Protein & Cell
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started